Cryptdin 13 inhibitors are a class of chemical compounds specifically designed to target and modulate the activity of cryptdin 13, a member of the defensin family of antimicrobial peptides found primarily in the intestinal tract of rodents. Cryptdin 13, like other cryptdins, plays a crucial role in the innate immune system by disrupting the membrane integrity of microbial pathogens, thereby protecting the host from infections. These peptides are produced by Paneth cells in the small intestine and are integral to maintaining gut microbial balance and overall intestinal health. Inhibitors of cryptdin 13 are developed to interfere with its antimicrobial activity, providing a means to study the specific functions of this peptide in gut immunity and microbial interactions.
The development of cryptdin 13 inhibitors begins with a detailed understanding of the peptide's structure and its mechanism of action. Cryptdins, including cryptdin 13, are characterized by their three-dimensional structure, which includes a series of disulfide bonds that stabilize their alpha-helical or beta-sheet configurations. Structural studies, such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, are employed to map the exact configuration of cryptdin 13, focusing on regions critical for its interaction with microbial membranes. Once these regions are identified, computational modeling and molecular docking techniques are used to design or screen for small molecules that can specifically bind to cryptdin 13, inhibiting its ability to interact with and disrupt microbial cell membranes. These inhibitors are then synthesized and tested in vitro to assess their binding affinity, specificity, and inhibitory potency. By blocking cryptdin 13 activity, these inhibitors allow researchers to explore the role of this peptide in gut immunity, microbial ecology, and the overall maintenance of intestinal health. The study of cryptdin 13 inhibitors provides valuable insights into the broader functions of antimicrobial peptides and their regulation within the immune system.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Glucocorticoid that can modulate immune responses, potentially affecting cryptdin 13 expression or activity. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Immunosuppressant that inhibits calcineurin, possibly influencing pathways related to cryptdin 13. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor, potentially affecting cell signaling pathways relevant to cryptdin 13 regulation. | ||||||
Mycophenolate mofetil | 128794-94-5 | sc-200971 sc-200971A | 20 mg 100 mg | $36.00 $107.00 | 1 | |
Immunosuppressive agent, potentially influencing lymphocyte function and related to cryptdin 13 activity. | ||||||
Azathioprine | 446-86-6 | sc-210853D sc-210853 sc-210853A sc-210853B sc-210853C | 500 mg 1 g 2 g 5 g 10 g | $199.00 $173.00 $342.00 $495.00 $690.00 | 1 | |
Immunosuppressive drug, potentially affecting cryptdin 13 expression through modulation of immune responses. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $76.00 $148.00 | 9 | |
Immunosuppressant, possibly impacting pathways involved in cryptdin 13 regulation. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $56.00 | 1 | |
Immunomodulatory drug, potentially affecting innate immune responses relevant to cryptdin 13. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Antimetabolite and immunosuppressant, potentially influencing pathways related to cryptdin 13 activity. | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $60.00 $75.00 $125.00 $205.00 | 8 | |
Anti-inflammatory drug, potentially modulating immune responses related to cryptdin 13. | ||||||